ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: Reports Lists 10 Recommendations TO Improve Quality of Care, Measurement

April 9, 1999

House Approves Additional Funds For NIH and FDA.

June 20, 2008

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

February 19, 2010

“Optimal Criteria,” For Hospitals Treating Cancer Patients Developed; NCI Won’t Try Forcing Changes

November 1, 1974

Lasker Official Urges Congressional Support Of NCI Bypass Budget

April 20, 1990

Schmidt Approve NCAB Authorizations

February 18, 1977